{"filing":{"accession_number":"0000816956-26-000057","cik":"0000816956","ticker":"CNMD","company_name":"CONMED Corp","form":"8-K","filing_date":"2026-05-20","report_date":null,"primary_document":"cnmd-20260518.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/816956/000081695626000057/cnmd-20260518.htm"},"events":[{"id":9671,"run_id":8479,"accession_number":"0000816956-26-000057","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"summary":"CONMED appointed two non-employee directors, Celine Martin and Jeff Mirviss, effective July 1, 2026, and appointed Kimberly Lockwood as Interim Corporate Controller and Interim Principal Accounting Officer effective June 1, 2026.","company_name":"CONMED Corp","ticker":"CNMD","filing_date":"2026-05-20","form":"8-K","submitted_at":null,"items":[{"id":435,"accession_number":"0000816956-26-000057","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The filing discloses the appointment of two non-employee directors (Celine Martin and Jeff Mirviss) effective July 1, 2026, and the appointment of Kimberly Lockwood as Interim Corporate Controller and Interim Principal Accounting Officer effective June 1, 2026. The principal disclosed action is the appointment of these individuals to significant roles. While the section also includes compensation details for the new directors, the core event is the appointment itself, making exec_appointment the most salient classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-21T02:39:12.465278+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":9672,"run_id":8479,"accession_number":"0000816956-26-000057","anchor_item_number":"5.03","event_type":"other_material","event_domain":"catchall","is_material":false,"confidence":0.85,"summary":"CONMED amended its bylaws to reflect Delaware law developments and market practice, including updates to advance notice provisions for stockholder nominations and director interview requirements.","company_name":"CONMED Corp","ticker":"CNMD","filing_date":"2026-05-20","form":"8-K","submitted_at":null,"items":[{"id":436,"accession_number":"0000816956-26-000057","item_number":"5.03","item_title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.","event_type":"other_material","event_domain":"catchall","is_material":false,"confidence":0.85,"reasoning":"The disclosure describes routine amendments to CONMED's bylaws to reflect Delaware law developments and market practice, including updates to advance notice provisions for stockholder nominations and director interview requirements. While bylaw amendments are formally disclosed under Item 5.03, these changes are administrative and procedural in nature—they do not affect the company's financial condition, operations, or governance structure in a way that would materially impact a reasonable investor's assessment of the registrant.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-21T02:39:12.465278+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":9673,"run_id":8479,"accession_number":"0000816956-26-000057","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"Shareholders approved all three proposals at CONMED's May 18, 2026 annual meeting: election of seven directors, advisory vote on named executive officer compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor, each with substantial majorities.","company_name":"CONMED Corp","ticker":"CNMD","filing_date":"2026-05-20","form":"8-K","submitted_at":null,"items":[{"id":437,"accession_number":"0000816956-26-000057","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a standard Item 5.07 disclosure of shareholder voting results from CONMED's May 18, 2026 annual meeting. The filing reports the outcomes of three proposals: election of seven directors, advisory vote on named executive officer compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor. All three proposals passed with substantial majorities, and the detailed vote tallies are provided for each director and proposal.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-21T02:39:12.465278+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":435,"accession_number":"0000816956-26-000057","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The filing discloses the appointment of two non-employee directors (Celine Martin and Jeff Mirviss) effective July 1, 2026, and the appointment of Kimberly Lockwood as Interim Corporate Controller and Interim Principal Accounting Officer effective June 1, 2026. The principal disclosed action is the appointment of these individuals to significant roles. While the section also includes compensation details for the new directors, the core event is the appointment itself, making exec_appointment the most salient classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-21T02:39:12.465278+00:00","company_name":"CONMED Corp","ticker":"CNMD","filing_date":"2026-05-20"},{"id":436,"accession_number":"0000816956-26-000057","item_number":"5.03","item_title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.","event_type":"other_material","event_domain":"catchall","is_material":false,"confidence":0.85,"reasoning":"The disclosure describes routine amendments to CONMED's bylaws to reflect Delaware law developments and market practice, including updates to advance notice provisions for stockholder nominations and director interview requirements. While bylaw amendments are formally disclosed under Item 5.03, these changes are administrative and procedural in nature—they do not affect the company's financial condition, operations, or governance structure in a way that would materially impact a reasonable investor's assessment of the registrant.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-21T02:39:12.465278+00:00","company_name":"CONMED Corp","ticker":"CNMD","filing_date":"2026-05-20"},{"id":437,"accession_number":"0000816956-26-000057","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a standard Item 5.07 disclosure of shareholder voting results from CONMED's May 18, 2026 annual meeting. The filing reports the outcomes of three proposals: election of seven directors, advisory vote on named executive officer compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor. All three proposals passed with substantial majorities, and the detailed vote tallies are provided for each director and proposal.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-21T02:39:12.465278+00:00","company_name":"CONMED Corp","ticker":"CNMD","filing_date":"2026-05-20"}]}